Optimal duration of dual antiplatelet therapy study after ACS.
Speaker Joao Morais
Event : Acute Cardiovascular Care 2016
- Topic : coronary artery disease, acute coronary syndromes, acute cardiac care
- Sub-topic : Acute Coronary Syndromes: Antiplatelet Agents
- Session type : Symposium
- Joint session with the ESC Working Group on Thrombosis - This session is supported by an unrestricted educational grant from AstraZeneca